July 6, 2011
NEW YORK (GenomeWeb News) – Unilabs will develop a companion diagnostic assay for a Biogen Idec drug for patients receiving a multiple sclerosis treatment, the Copenhagen-based firm said today.
Under the agreement, Unilabs will develop a two-step ELISA test to detect anti-JCV antibodies to help stratify patients receiving Biogen Idec’s Tysabri (natalizumab). The presence of anti-JCV antibodies is one of three risk factors, along with prior immunosuppressant use and treatment duration, used to calculate the risk of Tysabri-treated patients developing progressive multifocal leukoencephalopathy.
The firms have also developed a closed web interface to allow neurologists to order sampling and shipping materials, register sample pick-up details, and request language and format of analytical reports.
Further terms of the collaboration were not disclosed.
Source: Genome Web Daily
.
****************************************************************
Remain CURRENT with Multiple Sclerosis news
and information, when registered
at the MS Views and News website
~ Our weekly e-Newsletter is now reaching (87) Countries ~
DONATION$ are needed to help us to Educate
“MS Views and News” (MSV&N) is a 501©(3) organization as
recognized by the Internal Revenue Service
All contributions are tax deductible to the fullest extent allowed by law
.
“Providing You with ‘MS Views and News’, is what we do“
***************************************************************************************
.
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews